344 related articles for article (PubMed ID: 19666573)
1. Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells.
Wang R; Kozhaya L; Mercer F; Khaitan A; Fujii H; Unutmaz D
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13439-44. PubMed ID: 19666573
[TBL] [Abstract][Full Text] [Related]
2. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
Elkord E; Abd Al Samid M; Chaudhary B
Oncotarget; 2015 Aug; 6(24):20026-36. PubMed ID: 26343373
[TBL] [Abstract][Full Text] [Related]
3. GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo.
Zhou AX; Kozhaya L; Fujii H; Unutmaz D
J Immunol; 2013 May; 190(10):5057-64. PubMed ID: 23576681
[TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1 restores impaired GARPCD4⁺CD25⁺ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes.
Liu Y; Zhao X; Zhong Y; Meng K; Yu K; Shi H; Wu B; Tony H; Zhu J; Zhu R; Peng Y; Mao Y; Cheng P; Mao X; Zeng Q
Cell Physiol Biochem; 2015; 35(2):553-70. PubMed ID: 25612606
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in FoxP3- and GARP/LAP-Expressing T Regulatory Cells in an HLA Class II Transgenic Murine Model of Necrotizing Soft Tissue Infections by Group A Streptococcus.
Nookala S; Mukundan S; Fife A; Alagarsamy J; Kotb M
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30224551
[TBL] [Abstract][Full Text] [Related]
6. CD4
Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation.
Edwards JP; Fujii H; Zhou AX; Creemers J; Unutmaz D; Shevach EM
J Immunol; 2013 Jun; 190(11):5506-15. PubMed ID: 23645881
[TBL] [Abstract][Full Text] [Related]
8. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
[TBL] [Abstract][Full Text] [Related]
9. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
[TBL] [Abstract][Full Text] [Related]
10. Impairment of Circulating CD4⁺CD25⁺GARP⁺ regulatory T cells in patients with acute coronary syndrome.
Meng K; Zhang W; Zhong Y; Mao X; Lin Y; Huang Y; Lang M; Peng Y; Zhu Z; Liu Y; Zhao X; Yu K; Wu B; Ji Q; Zeng Q
Cell Physiol Biochem; 2014; 33(3):621-32. PubMed ID: 24603196
[TBL] [Abstract][Full Text] [Related]
11. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells.
Tran DQ; Andersson J; Wang R; Ramsey H; Unutmaz D; Shevach EM
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13445-50. PubMed ID: 19651619
[TBL] [Abstract][Full Text] [Related]
12. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
13. Expansion of GARP-Expressing CD4
Teer E; Joseph DE; Dominick L; Glashoff RH; Essop MF
Virol Sin; 2021 Oct; 36(5):1133-1143. PubMed ID: 33974229
[TBL] [Abstract][Full Text] [Related]
14. In vitro Conversion into CD4+CD25+Foxp3+ Induced Regulatory T Cells Is Reduced in Atopic Dermatitis Patients.
García EM; Galicia-Carreón J; Novak N
Int Arch Allergy Immunol; 2020; 181(5):353-356. PubMed ID: 32160611
[TBL] [Abstract][Full Text] [Related]
15. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
16. The Tregs' world according to GARP.
Battaglia M; Roncarolo MG
Eur J Immunol; 2009 Dec; 39(12):3296-300. PubMed ID: 19904770
[TBL] [Abstract][Full Text] [Related]
17. GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing.
Sun L; Jin H; Li H
Oncotarget; 2016 Jul; 7(27):42826-42836. PubMed ID: 27095576
[TBL] [Abstract][Full Text] [Related]
18. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression.
Wang R; Wan Q; Kozhaya L; Fujii H; Unutmaz D
PLoS One; 2008 Jul; 3(7):e2705. PubMed ID: 18628982
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of GARP expression on regulatory T cells by protein transport inhibitors.
Anvari S; Schuster K; Grimbergen A; Davis CM; Makedonas G
J Immunol Methods; 2021 May; 492():112998. PubMed ID: 33600819
[TBL] [Abstract][Full Text] [Related]
20. Garp as a therapeutic target for modulation of T regulatory cell function.
Shevach EM
Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
